Literature DB >> 11641791

Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.

Y Okutani1, A Kitanaka, T Tanaka, H Kamano, H Ohnishi, Y Kubota, T Ishida, J Takahara.   

Abstract

Signal transducers and activators of transcription (STAT) proteins are transcription factors activated by phosphorylation on tyrosine residues after cytokine stimulation. In erythropoietin receptor (EPOR)-mediated signaling, STAT5 is tyrosine-phosphorylated by EPO stimulation. Although Janus Kinase 2 (JAK2) is reported to play a crucial role in EPO-induced activation of STAT5, it is unclear whether JAK2 alone can tyrosine-phosphorylate STAT5 after EPO stimulation. Several studies indicate that STAT activation is caused by members of other families of protein tyrosine kinases such as the Src family. We previously reported that reduction of Src by induction of antisense src RNA expression suppressed EPO-promoted erythroid differentiation in K562 cells. In the present study, we explored the function of Src downstream of the EPOR-initiated signaling. Reduction of Src diminished tyrosine phosphorylation of STAT5 in K562 cells regardless of EPO treatment. The tyrosine phosphorylation level of STAT5 induced by EPO in F-36P cells was reduced in the presence of PP1 or PP2 selective Src inhibitor. In addition, the expression of dominant negative Src in F-36P cells reduced the tyrosine phosphorylation of STAT5. When Src and STAT5 were co-expressed in COS7 cells, tyrosine phosphorylation of STAT5 was observed, and tyrosine residue 694 (Tyr 694) of STAT5A was identified as the major phosphorylation site by Src. In vitro kinase assay revealed that GST-STAT5 fusion protein with the conserved C-terminal, but not the C-terminal-truncated mutant which lacks Tyr 694, was tyrosine-phosphorylated by Src. Src can thus directly tyrosine-phosphorylate the activation site of STAT5 (Tyr 694 in STAT5A), and Src may contribute to EPO-induced signal transduction via STAT5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641791     DOI: 10.1038/sj.onc.1204807

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.

Authors:  Jeffrey W Tyner; Denise K Walters; Stephanie G Willis; Mary Luttropp; Jason Oost; Marc Loriaux; Heidi Erickson; Amie S Corbin; Thomas O'Hare; Michael C Heinrich; Michael W Deininger; Brian J Druker
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

2.  Hck is a key regulator of gene expression in alternatively activated human monocytes.

Authors:  Ashish Bhattacharjee; Srabani Pal; Gerald M Feldman; Martha K Cathcart
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

3.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.

Authors:  Agata Klejman; Steven J Schreiner; Malgorzata Nieborowska-Skorska; Artur Slupianek; Matthew Wilson; Thomas E Smithgall; Tomasz Skorski
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

4.  STAT5: a Target of Antagonism by Neurotropic Flaviviruses.

Authors:  Matthew G Zimmerman; James R Bowen; Circe E McDonald; Ellen Young; Ralph S Baric; Bali Pulendran; Mehul S Suthar
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

5.  Arsenic disulfide induced apoptosis and concurrently promoted erythroid differentiation in cytokine-dependent myelodysplastic syndrome-progressed leukemia cell line F-36p with complex karyotype including monosomy 7.

Authors:  Xiao-mei Hu; Sachiko Tanaka; Kenji Onda; Bo Yuan; Hiroo Toyoda; Rou Ma; Feng Liu; Toshihiko Hirano
Journal:  Chin J Integr Med       Date:  2014-03-07       Impact factor: 1.978

6.  Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.

Authors:  Y Kubota; T Tanaka; A Kitanaka; H Ohnishi; Y Okutani; M Waki; T Ishida; H Kamano
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

7.  A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells.

Authors:  Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

8.  Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells.

Authors:  Abdul Qader Omer Al-Aidaroos; Hiu Fung Yuen; Ke Guo; Shu Dong Zhang; Tae-Hoon Chung; Wee Joo Chng; Qi Zeng
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

9.  c-Src tyrosine kinase co-associates with and phosphorylates signal transducer and activator of transcription 5b which mediates the proliferation of normal human B lymphocytes.

Authors:  M-P Cayer; M Proulx; X-Z Ma; D Sakac; J-F Giguère; M Drouin; S Néron; D R Branch; D Jung
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

10.  Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase.

Authors:  Olivier Kosmider; Dorothée Buet; Isabelle Gallais; Nicole Denis; Françoise Moreau-Gachelin
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.